Exhibit 1. Relative risk meta-analysis of response rates comparing citalopram to escitalopram.

Exhibit 1Relative risk meta-analysis of response rates comparing citalopram to escitalopram

Characteristics of included studies
Sample sizeMean AgeWomenDurationScale
Burke et al., 20025749140.165%8 weeksMADRS
Colonna et al., 2005583574675%8 weeksMADRS
Lepola et al., 2003564714372.1%8 weeksMADRS
Moore et al., 20055928045.276.9%8 weeksMADRS
SCT-MD-02 (unpublished)6124341.952.6%8 weeksMADRS
Yevtushenko et al., 20076033034.958.4%6 weeksMADRS

From: Results

Cover of Drug Class Review: Second-Generation Antidepressants
Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report [Internet].
Gartlehner G, Hansen RA, Reichenpfader U, et al.
Portland (OR): Oregon Health & Science University; 2011 Mar.
Copyright © 2011 Oregon Health & Science University.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.